| Product Code: ETC13158027 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Onchocerciasis Market was valued at USD 0.3 Billion in 2024 and is expected to reach USD 0.4 Billion by 2031, growing at a compound annual growth rate of 4.90% during the forecast period (2025-2031).
The Global Onchocerciasis Market encompasses the various diagnostic tests, treatment options, and preventive measures aimed at combating the parasitic disease onchocerciasis, also known as river blindness. Key players in this market include pharmaceutical companies developing drugs such as ivermectin and doxycycline, as well as organizations providing community-based treatment programs and vector control strategies. The market is driven by the high prevalence of onchocerciasis in sub-Saharan Africa and parts of Latin America, leading to a significant economic burden and public health concern. Efforts to eliminate the disease have been supported by initiatives such as the World Health Organization`s Onchocerciasis Control Program, which has led to the successful reduction of infection rates in many endemic regions. Ongoing research and partnerships within the Global Onchocerciasis Market aim to further improve treatment accessibility and disease management strategies.
The Global Onchocerciasis Market is witnessing a growing demand for innovative treatment options and increased efforts towards disease eradication. Key trends include the development of new therapeutic interventions such as novel drug formulations and targeted therapies, as well as the advancement of diagnostic tools for early detection. Opportunities in the market stem from the focus on public health initiatives aimed at eliminating onchocerciasis as a public health problem by 2030, creating a favorable environment for market growth. Additionally, partnerships between pharmaceutical companies, governments, and non-profit organizations to increase access to treatment in endemic regions present opportunities for market expansion. Overall, the market is poised for significant growth driven by the increasing awareness of the disease and concerted efforts towards its control and eradication.
One of the primary challenges in the Global Onchocerciasis Market is the lack of access to affected populations in remote and underserved regions, particularly in developing countries. Limited healthcare infrastructure, poor transportation networks, and socio-economic factors can hinder the delivery of necessary medications and treatments to those in need. Additionally, funding constraints for research and development of new therapies, as well as inadequate awareness and education about the disease, pose significant challenges in effectively combating onchocerciasis. Addressing these obstacles requires a multi-faceted approach involving collaboration between governments, non-profit organizations, pharmaceutical companies, and healthcare providers to improve access to care, increase funding for research, and raise awareness about the impact of onchocerciasis on affected communities.
The global onchocerciasis market is primarily driven by the increasing prevalence of the disease in endemic regions, particularly in sub-Saharan Africa. The urgent need for effective treatment strategies and control measures to combat this neglected tropical disease is also a significant driver for market growth. Additionally, government initiatives and partnerships with international organizations to eliminate onchocerciasis, along with the development of novel drug therapies and diagnostic tools, are contributing to the expansion of the market. Furthermore, the growing awareness among healthcare professionals and the general population about the impact of onchocerciasis on public health is fueling the demand for innovative solutions, driving market growth in the global onchocerciasis sector.
Government policies related to the Global Onchocerciasis Market focus on promoting prevention and treatment programs to control the spread of the disease. Many governments in endemic regions collaborate with international organizations and pharmaceutical companies to provide free or subsidized distribution of anti-parasitic drugs, such as ivermectin, to at-risk populations. These policies aim to eliminate onchocerciasis as a public health problem by 2030, in line with the World Health Organization`s goals for neglected tropical diseases. Additionally, governments may implement vector control measures, community education initiatives, and surveillance programs to monitor progress and ensure effective management of the disease. Overall, government policies in the Global Onchocerciasis Market prioritize the health and well-being of affected populations through comprehensive strategies that address the root causes of onchocerciasis transmission.
The Global Onchocerciasis Market is expected to witness moderate growth in the coming years, driven by initiatives aimed at controlling and eliminating the disease. With continued efforts from organizations like the World Health Organization and pharmaceutical companies focusing on developing new treatments and preventive measures, the market is poised for advancements. Additionally, improved healthcare infrastructure in endemic regions and rising awareness about onchocerciasis are likely to contribute to market growth. However, challenges such as limited access to healthcare in remote areas and the high cost associated with treatment may hinder the market`s expansion. Overall, the Global Onchocerciasis Market is projected to show steady progress, with a focus on innovation and collaboration to combat this neglected tropical disease.
In the global onchocerciasis market, different regions exhibit varying trends. In Asia, onchocerciasis is primarily concentrated in countries like Yemen and Saudi Arabia, with ongoing efforts to control the disease through mass drug administration programs. North America has a low prevalence of onchocerciasis, mainly seen in immigrants from endemic regions. In Europe, cases are sporadic due to travel-related infections, with countries like France and Portugal reporting occasional cases. The Middle East and Africa bear the highest burden of onchocerciasis, particularly in sub-Saharan Africa where the disease is endemic. Latin America has made significant progress in eliminating onchocerciasis, with Brazil being the only country still grappling with localized transmission. Overall, efforts in these regions focus on prevention, control, and elimination strategies tailored to their specific epidemiological contexts.
Global Onchocerciasis Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Onchocerciasis Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Onchocerciasis Market Revenues & Volume, 2021 & 2031F |
3.3 Global Onchocerciasis Market - Industry Life Cycle |
3.4 Global Onchocerciasis Market - Porter's Five Forces |
3.5 Global Onchocerciasis Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Onchocerciasis Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.7 Global Onchocerciasis Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.8 Global Onchocerciasis Market Revenues & Volume Share, By Drug, 2021 & 2031F |
3.9 Global Onchocerciasis Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 Global Onchocerciasis Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.11 Global Onchocerciasis Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Global Onchocerciasis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Onchocerciasis Market Trends |
6 Global Onchocerciasis Market, 2021 - 2031 |
6.1 Global Onchocerciasis Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Onchocerciasis Market, Revenues & Volume, By Physical Examination, 2021 - 2031 |
6.1.3 Global Onchocerciasis Market, Revenues & Volume, By Skin Biopsy, 2021 - 2031 |
6.1.4 Global Onchocerciasis Market, Revenues & Volume, By Mazzotti Test, 2021 - 2031 |
6.1.5 Global Onchocerciasis Market, Revenues & Volume, By Nodulectomy, 2021 - 2031 |
6.1.6 Global Onchocerciasis Market, Revenues & Volume, By PCR Test, 2021 - 2031 |
6.1.7 Global Onchocerciasis Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Global Onchocerciasis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Onchocerciasis Market, Revenues & Volume, By Medication, 2021 - 2031 |
6.2.3 Global Onchocerciasis Market, Revenues & Volume, By Supportive Care, 2021 - 2031 |
6.2.4 Global Onchocerciasis Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 Global Onchocerciasis Market, Revenues & Volume, By Drug, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Onchocerciasis Market, Revenues & Volume, By Ivermectin, 2021 - 2031 |
6.3.3 Global Onchocerciasis Market, Revenues & Volume, By Moxidectin, 2021 - 2031 |
6.3.4 Global Onchocerciasis Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 Global Onchocerciasis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Onchocerciasis Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.4.3 Global Onchocerciasis Market, Revenues & Volume, By Others, 2021 - 2031 |
6.5 Global Onchocerciasis Market, Revenues & Volume, By End User, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global Onchocerciasis Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.5.3 Global Onchocerciasis Market, Revenues & Volume, By Homecare, 2021 - 2031 |
6.5.4 Global Onchocerciasis Market, Revenues & Volume, By Specialty Clinics, 2021 - 2031 |
6.5.5 Global Onchocerciasis Market, Revenues & Volume, By Others, 2021 - 2031 |
6.6 Global Onchocerciasis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.6.1 Overview & Analysis |
6.6.2 Global Onchocerciasis Market, Revenues & Volume, By Hospital Pharmacy, 2021 - 2031 |
6.6.3 Global Onchocerciasis Market, Revenues & Volume, By Online Pharmacy, 2021 - 2031 |
6.6.4 Global Onchocerciasis Market, Revenues & Volume, By Retail Pharmacy, 2021 - 2031 |
7 North America Onchocerciasis Market, Overview & Analysis |
7.1 North America Onchocerciasis Market Revenues & Volume, 2021 - 2031 |
7.2 North America Onchocerciasis Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Onchocerciasis Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Onchocerciasis Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Onchocerciasis Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Onchocerciasis Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
7.4 North America Onchocerciasis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
7.5 North America Onchocerciasis Market, Revenues & Volume, By Drug, 2021 - 2031 |
7.6 North America Onchocerciasis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.7 North America Onchocerciasis Market, Revenues & Volume, By End User, 2021 - 2031 |
7.8 North America Onchocerciasis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Latin America (LATAM) Onchocerciasis Market, Overview & Analysis |
8.1 Latin America (LATAM) Onchocerciasis Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Onchocerciasis Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Onchocerciasis Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Onchocerciasis Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Onchocerciasis Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Onchocerciasis Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Onchocerciasis Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
8.4 Latin America (LATAM) Onchocerciasis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
8.5 Latin America (LATAM) Onchocerciasis Market, Revenues & Volume, By Drug, 2021 - 2031 |
8.6 Latin America (LATAM) Onchocerciasis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
8.7 Latin America (LATAM) Onchocerciasis Market, Revenues & Volume, By End User, 2021 - 2031 |
8.8 Latin America (LATAM) Onchocerciasis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9 Asia Onchocerciasis Market, Overview & Analysis |
9.1 Asia Onchocerciasis Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Onchocerciasis Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Onchocerciasis Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Onchocerciasis Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Onchocerciasis Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Onchocerciasis Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Onchocerciasis Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
9.4 Asia Onchocerciasis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
9.5 Asia Onchocerciasis Market, Revenues & Volume, By Drug, 2021 - 2031 |
9.6 Asia Onchocerciasis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
9.7 Asia Onchocerciasis Market, Revenues & Volume, By End User, 2021 - 2031 |
9.8 Asia Onchocerciasis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10 Africa Onchocerciasis Market, Overview & Analysis |
10.1 Africa Onchocerciasis Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Onchocerciasis Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Onchocerciasis Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Onchocerciasis Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Onchocerciasis Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Onchocerciasis Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Onchocerciasis Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
10.4 Africa Onchocerciasis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
10.5 Africa Onchocerciasis Market, Revenues & Volume, By Drug, 2021 - 2031 |
10.6 Africa Onchocerciasis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
10.7 Africa Onchocerciasis Market, Revenues & Volume, By End User, 2021 - 2031 |
10.8 Africa Onchocerciasis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11 Europe Onchocerciasis Market, Overview & Analysis |
11.1 Europe Onchocerciasis Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Onchocerciasis Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Onchocerciasis Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Onchocerciasis Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Onchocerciasis Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Onchocerciasis Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Onchocerciasis Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
11.4 Europe Onchocerciasis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
11.5 Europe Onchocerciasis Market, Revenues & Volume, By Drug, 2021 - 2031 |
11.6 Europe Onchocerciasis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
11.7 Europe Onchocerciasis Market, Revenues & Volume, By End User, 2021 - 2031 |
11.8 Europe Onchocerciasis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12 Middle East Onchocerciasis Market, Overview & Analysis |
12.1 Middle East Onchocerciasis Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Onchocerciasis Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Onchocerciasis Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Onchocerciasis Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Onchocerciasis Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Onchocerciasis Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
12.4 Middle East Onchocerciasis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
12.5 Middle East Onchocerciasis Market, Revenues & Volume, By Drug, 2021 - 2031 |
12.6 Middle East Onchocerciasis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
12.7 Middle East Onchocerciasis Market, Revenues & Volume, By End User, 2021 - 2031 |
12.8 Middle East Onchocerciasis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
13 Global Onchocerciasis Market Key Performance Indicators |
14 Global Onchocerciasis Market - Export/Import By Countries Assessment |
15 Global Onchocerciasis Market - Opportunity Assessment |
15.1 Global Onchocerciasis Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Onchocerciasis Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
15.3 Global Onchocerciasis Market Opportunity Assessment, By Treatment, 2021 & 2031F |
15.4 Global Onchocerciasis Market Opportunity Assessment, By Drug, 2021 & 2031F |
15.5 Global Onchocerciasis Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
15.6 Global Onchocerciasis Market Opportunity Assessment, By End User, 2021 & 2031F |
15.7 Global Onchocerciasis Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
16 Global Onchocerciasis Market - Competitive Landscape |
16.1 Global Onchocerciasis Market Revenue Share, By Companies, 2024 |
16.2 Global Onchocerciasis Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here